首页> 美国卫生研究院文献>Journal of the Royal Society Interface >Comparison of a poly-l-lactide-co-ɛ-caprolactone and human amniotic membrane for urothelium tissue engineering applications
【2h】

Comparison of a poly-l-lactide-co-ɛ-caprolactone and human amniotic membrane for urothelium tissue engineering applications

机译:聚l-丙交酯-co-己内酯与人羊膜在尿路上皮组织工程应用中的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The reconstructive surgery of urothelial defects, such as severe hypospadias is susceptible to complications. The major problem is the lack of suitable grafting materials. Therefore, finding alternative treatments such as reconstruction of urethra using tissue engineering is essential. The aim of this study was to compare the effects of naturally derived acellular human amniotic membrane (hAM) to synthetic poly-l-lactide-co-ε-caprolactone (PLCL) on human urothelial cell (hUC) viability, proliferation and urothelial differentiation level. The viability of cells was evaluated using live/dead staining and the proliferation was studied using WST-1 measurement. Cytokeratin (CK)7/8 and CK19 were used to confirm that the hUCs maintained their phenotype on different biomaterials. On the PLCL, the cell number significantly increased during the culturing period, in contrast to the hAM, where hUC proliferation was the weakest at 7 and 14 days. In addition, the majority of cells were viable and maintained their phenotype when cultured on PLCL and cell culture plastic, whereas on the hAM, the viability of hUCs decreased with time and the cells did not maintain their phenotype. The PLCL membranes supported the hUC proliferation significantly more than the hAM. These results revealed the significant potential of PLCL membranes in urothelial tissue engineering applications.
机译:尿道上皮缺损(例如严重的尿道下裂)的重建手术容易出现并发症。主要的问题是缺乏合适的接枝材料。因此,寻找替代疗法,例如使用组织工程技术重建尿道至关重要。这项研究的目的是比较天然来源的脱细胞人羊膜(hAM)与合成的聚丙交酯-共-ε-己内酯(PLCL)对人尿路上皮细胞(hUC)活力,增殖和尿路上皮分化水平的影响。使用活/死染色评估细胞的活力,并使用WST-1测量研究增殖。细胞角蛋白(CK)7/8和CK19用于确认hUC在不同的生物材料上保持其表型。在PLCL上,与hAM(在7天和14天时hUC增殖最弱)的hAM相反,细胞数量在培养期间显着增加。此外,当在PLCL和细胞培养塑料上培养时,大多数细胞都具有活力并保持其表型,而在hAM上,hUCs的活力随时间下降,并且细胞未保持其表型。 PLCL膜比hAM显着更多地支持hUC增殖。这些结果揭示了PLCL膜在尿路上皮组织工程应用中的巨大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号